Cathie Wood Doubled Her Stakes in These 5 Stocks in 2022

2. Nurix Therapeutics, Inc. (NASDAQ:NRIX)

Number of Hedge Fund Holders: 25   

Percentage Increase in Stake During Q1: 792%

Nurix Therapeutics, Inc. (NASDAQ:NRIX) is a biopharma firm based in California. ARK first purchased a stake in the firm during the fourth quarter of 2021, buying close to 44,000 shares at an average price of $30.32 per share. As the share price of the stock fell to around $17, the fund increased its stake in the firm and now owns over 391,000 shares in the company worth $5.4 million, representing 0.02% of the portfolio. 

On April 14, investment advisory HC Wainwright maintained a Buy rating on Nurix Therapeutics, Inc. (NASDAQ:NRIX) stock and lowered the price target to $60 from $62. Analyst Robert Burns issued the ratings update. 

At the end of the fourth quarter of 2021, 25 hedge funds in the database of Insider Monkey held stakes worth $287 million in Nurix Therapeutics, Inc. (NASDAQ:NRIX), compared to 18 in the preceding quarter worth $313 million.